Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Caris Life Sciences (CAI) Current Assets (2024 - 2025)

Caris Life Sciences has reported Current Assets over the past 2 years, most recently at $997.8 million for Q4 2025.

  • Quarterly results put Current Assets at $997.8 million for Q4 2025, up 362.52% from a year ago — trailing twelve months through Dec 2025 was $997.8 million (up 362.52% YoY), and the annual figure for FY2025 was $997.8 million, up 362.52%.
  • Current Assets for Q4 2025 was $997.8 million at Caris Life Sciences, up from $854.2 million in the prior quarter.
  • Over the last five years, Current Assets for CAI hit a ceiling of $997.8 million in Q4 2025 and a floor of $215.7 million in Q4 2024.